Close menu




March 2nd, 2026 | 07:40 CET

First Majestic Silver hits an all-time high! Could Silver Viper Minerals be next? Resistance at Bayer!

  • Mining
  • Silver
  • Commodities
  • Pharma
Photo credits: üioxabay

The silver rally is far from over, as the price of the precious metal has stabilized at a high level of USD 90 per ounce, enabling the industry to generate high revenues. First Majestic is an impressive example, with investors celebrating record figures that pushed the stock to a new all-time high last week. Similarly, Silver Viper Minerals is drawing attention, offering clear growth targets and fueling takeover speculation. The CEO made a convincing case at an investor conference last week, outlining the Canadians’ 2026 motto: “drill, drill, drill.” At the same time, the company aims to grow through acquisitions, likely ensuring an exciting news flow. Meanwhile, at Bayer, the focus is back on glyphosate. Recent optimism about an end to the saga had driven the stock higher, but now, resistance is emerging.

time to read: 3 minutes | Author: Fabian Lorenz
ISIN: FIRST MAJESTIC SILVER | CA32076V1031 , SILVER VIPER MINER. CORP. | CA8283344098 | TSXV: VIPR , OTCQB: VIPRF , BAYER AG NA O.N. | DE000BAY0017

Table of contents:


    Silver Viper Minerals: “Drill, drill, drill” and takeover speculation

    Silver Viper Minerals outlined a clear growth path at last week’s IIF investor conference. And CEO Stephen Cope provided several short-term catalysts. First, there is the Coneto deal. After delays due to the update of the NI 43-101 report, this is now expected to be completed “in the next one to two weeks.” After closing, Coneto will be aggressively advanced with two drilling rigs. Cope also indicated that the company plans to continue to grow as an active explorer in Mexico and that additional acquisitions are an option. At the same time, drilling is already underway at the flagship La Virginia project. Extensive historical and current drilling data have already created a robust resource base with recovery rates of 90% to 95%.

    Fundamentally, Silver Viper is positioned with two resource pillars and an attractive gold-silver mix. La Virginia currently has around 700,000 gold equivalent ounces (approximately 60% gold / 40% silver) and, in the management’s view, offers “plenty of room” for the leap towards a multi-million-ounce project. Coneto stands at around 535,000 gold equivalent ounces (approximately 50/50 gold/silver). There, too, the aim is to significantly increase the scale of the project in the future. The strategic environment is conducive to this. Good infrastructure and support from local communities should reduce risks, while the geology offers abundant potential.

    The capital market positioning also looks sound. Cope emphasized a neat and tidy shareholder structure, strong institutional support from well-known commodity investors/funds, and a clear focus on value drivers. “Drill, drill, drill” is the clear strategy. Even in tighter capital markets, drilling is the non-negotiable priority in order to “dramatically” expand resources in 12 to 18 months. This should also make the company a takeover candidate.

    https://youtu.be/8XvydXs-waA?si=5sFPh1MgZSGE7m2u

    First Majestic Silver celebrates record highs

    While Silver Viper’s share price is still a long way off its January high of CAD 2.57 and is tempting investors at its current price of CAD 1.55, First Majestic Silver shot to a new all-time high on Friday. At a price of CAD 43.64, the silver group is now worth over CAD 21 billion on the stock market. To put this into perspective, 12 months ago, the share price was below CAD 8.

    The share price was driven by strong figures last week. First Majestic reported on the fourth quarter of 2025. In this quarter, the company increased silver production by 77% to 4.2 million ounces, setting a new record.

    Revenue rose even more sharply. It climbed 169% year-on-year to USD 463.9 million. This resulted in net income of USD 105.2 million, or USD 0.17 per share. In the same quarter of the previous year, a net loss of USD 13.5 million was reported. Operating cash flow shot up to USD 301.0 million, or USD 0.61 per share, in the last quarter of 2025. In the same quarter of the previous year, it was only USD 62.4 million, or USD 0.21 per share. Due to the record figures, a quarterly dividend of USD 0.0083 per share is to be distributed.

    Bayer: Glyphosate lawsuits not over yet?

    From mid-November 2025 to mid-February 2026, Bayer’s share price climbed from around EUR 27 to around EUR 50. This rise was partly driven by investor optimism that the glyphosate saga might finally be resolved, possibly through a US Supreme Court decision. To facilitate this, a USD 7.25 billion settlement was proposed.

    But it does not seem to be that simple for the Leverkusen-based company. Resistance is mounting. Lawyers have filed a motion in the US state of Missouri to postpone the decision by at least 60 days. They represent 20,000 plaintiffs. A total of around 65,000 lawsuits are pending in the US relating to glyphosate.

    When announcing the settlement on February 17, 2026, Bayer CEO Bill Anderson emphasized that the "overwhelming majority" of plaintiffs must participate for the agreement to proceed. If this condition is not met, Bayer retains the option to withdraw from the settlement.

    Bayer shares have lost some steam in recent days. Over the past two weeks, they have lost around 15% of their value and were trading at EUR 42 on Friday. However, over the past 12 months, the share price has still risen by an impressive 84%.


    The silver rally is far from over. The price has stabilized at a high level and is giving the industry a boost. First Majestic remains a core investment in the sector. Silver Viper Minerals is likely to have a surprise or two in store this year. And then, of course, there is the takeover speculation. Bayer shares have performed very well in recent months. A prolonged consolidation would come as no surprise.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author



    Related comments:

    Commented by Stefan Feulner on June 12th, 2026 | 07:10 CEST

    BYD, Standard Uranium, FuelCell Energy: The Battle for Electricity Creates New Stock Market Stars

    • Mining
    • Uranium
    • Energy
    • renewableenergy
    • Electromobility
    • Fuelcells

    Global electricity demand is rising rapidly. AI data centers, electric mobility, and the electrification of industry are driving investment in alternative energy to record levels. Several future-oriented industries are benefiting from this: hydrogen and fuel cell technologies could play a key role in energy supply, while the renaissance of nuclear energy is ushering in a new phase of growth for the uranium market. At the same time, the global electric vehicle boom is driving sustained high demand for innovative mobility solutions.

    Read

    Commented by Nico Popp on June 12th, 2026 | 06:50 CEST

    Geostrategic Raw Materials Alliance: Export Controls Hit SpaceX and Rheinmetall – Wall Street Bets on Almonty

    • Mining
    • Tungsten
    • Defense
    • hightech
    • geopolitics
    • Space

    Trade barriers, reduced mining quotas, and a US legal import ban on certain critical metals set to take effect in 2027—the West's traditional raw materials supply chains are under pressure. At the heart of the supply bottleneck is tungsten, which, due to its melting point of 3,422 °C, is irreplaceable for modern kinetic military applications and high-temperature-resistant alloys in the aerospace sector. Since alternative, non-Chinese production capacities have so far accounted for less than 10% of global production volume, Western technology companies face a very real supply crisis. Tungsten heavyweight Almonty Industries is stepping into this supply vacuum and, thanks to new production capacities, is emerging as a key player and de facto monopolist.

    Read

    Commented by Armin Schulz on June 12th, 2026 | 06:40 CEST

    The Biotech and Life Sciences Boom: Evotec, BioNxt Solutions, and Merck – Which Is Worth Investing In?

    • Biotechnology
    • Biotech
    • Pharma
    • LifeSciences

    The life sciences and pharmaceutical industry is undergoing a structural transformation. Value creation is no longer driven by individual blockbuster drugs, but rather by platform technologies, patent portfolios, and strategic deals. This new capital market logic rewards companies with protectable intellectual property and smart licensing agreements—not just pure pipeline developers. For private investors, this creates high-yield niches with reduced regulatory risks. The key question remains: who controls the levers in the innovation ecosystem? Those who recognize this structure early can benefit disproportionately. Today we focus on Evotec, BioNxt Solutions, and Merck.

    Read